首页 > 市场调查报告书 > 食物/饮料

食品添加剂

市场调查报告书

商品编码

1560819

全球亲水胶体市场 - 2024 - 2031

Global Hydrocolloids Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

全球亲水胶体市场在 2023 年达到 113.2 亿美元，预计到 2031 年将达到 177.8 亿美元，2024-2031 年预测期间复合年增长率为 5.8%。

亲水胶体是亲水性聚合物分散在水中的胶体系统。这些聚合物可以源自各种来源，包括植物、动物、微生物或合成来源，它们通常含有大量羟基，这增强了它们结合水的能力。不同量的水的存在使得亲水胶体根据环境的浓度和条件以不同的状态存在，例如凝胶或溶液。

水胶体敷料因其能够创造湿润的癒合环境、吸收渗出物并保护伤口免受外部污染物的影响而广泛应用于临床环境中各种类型的伤口。这些敷料含有亲水性聚合物，当与伤口液体接触时会形成凝胶，具有多种优点。

水胶体敷料产生的凝胶层有助于维持伤口周围的湿润环境，这对于最佳癒合至关重要。水分促进细胞迁移、增生和新组织的形成，加速癒合过程。

市场动态：

司机

伤口和外科手术发生率上升

全球亲水胶体市场的需求受到多种因素的推动。主要因素之一是伤口和外科手术发生率的上升。急性和慢性伤口数量的增加，特别是在老化人口中，是亲水胶体市场的重要驱动力。

手术伤口的复杂程度各不相同，从小切口到留下更大、更复杂伤口的大手术。水胶体敷料对于处理这些伤口特别有效，因为它们能够维持湿润的环境，这对于癒合至关重要。外科手术的数量是需要伤口护理的广大患者群。每次手术都存在併发症的风险，包括感染和延迟癒合，因此有效的伤口管理至关重要。

此外，该行业的主要参与者拥有技术进步和产品发布，这将推动该市场的成长。水胶体敷料的创新包括抗菌剂的整合。这些药物有助于预防感染，这是伤口护理中常见的併发症。透过减少伤口部位的微生物负荷，抗菌水胶体敷料可以提高癒合率并降低伤口相关感染的发生率。

此外，2023 年 8 月，Scapa Healthcare 成功协助一家全球消费品公司在创纪录的时间内推出了以水胶体为基础的医疗设备。该公司旨在推出一种新的医疗级亲肤水胶体产品，但缺乏内部开发该产品的监管专业知识和能力。

限制

与贴片相关的过敏反应和皮肤刺激、与传统敷料相比成本较高以及缺乏临床知识和培训等因素预计将阻碍市场的发展。

细分市场分析

全球亲水胶体市场根据类型、应用、最终用户和地区进行细分。

烧伤领域约占全球亲水胶体市场份额的 54.2%

烧伤领域预计将在预测期内占据最大的市场份额。水胶体敷料由于能够创造和维持湿润的癒合环境，因此在处理烧伤伤口方面特别有效。

水胶体敷料提供的水分在为细胞迁移创造最佳微环境方面发挥着至关重要的作用，这对于伤口癒合至关重要。在潮湿的环境中，成纤维细胞和角质形成细胞等细胞可以更容易地穿过伤口床，促进肉芽组织的形成和上皮细胞的再形成，最终加速整个癒合过程。

此外，产业产品推出的主要参与者将推动该市场的成长。例如，主要参与者之一的康德乐水胶体敷料是一种先进的伤口护理产品，专门用于维持湿润的癒合环境，这对于有效的伤口管理至关重要。这种敷料特别适用于各种类型的伤口，包括压疮、轻微烧伤和手术后伤口。

同样，3M 推出的 3M Tegaderm 水胶体敷料、Nexcare 水胶体和 3M Nu-Derm 标准水胶体敷料也有助于推动这一市场的成长。

此外，业内其他参与者还推出了 BAND-AID 品牌 HYDRO SEAL 用途水胶体凝胶绷带，为治疗小伤口提供了全面的解决方案，在单一绷带中提供了六大主要优点。

市场地域占有率

北美约占全球亲水胶体市场份额的43.1%

预计北美地区将在预测期内占据最大的市场份额。糖尿病足溃疡、压疮和腿部静脉溃疡等慢性伤口盛行率的上升，大大推动了亲水胶体市场的发展，特别是在伤口护理领域。慢性伤口在癒合过程中面临独特的挑战，需要专门的敷料来有效控制水分含量并促进癒合。水胶体敷料对于这些目的特别有效，导致医疗保健领域的需求增加。

此外，北美人口老化日益严重，也更容易罹患慢性病和伤口。技术进步、医疗保健支出增加以及有利的报销政策正在帮助推动这一市场的成长。

例如，领先的医疗产品製造商 3M 宣布推出专为管理慢性伤口而设计的新型先进水胶体敷料系列。这条创新产品线预计将对北美亲水胶体市场产生重大影响，体现了 3M 推动伤口护理技术进步的承诺。

此外，在该地区，大量关键参与者的存在、先进的医疗保健基础设施以及亲水胶体领域的关键参与者製造商推动了该市场的成长。例如，2023 年9 月在拉斯维加斯Regenerex 上，Pharma, Inc. 宣布组成综合管理团队，并计划于2023 年第四季开始生产营运。专有配方快速伤口，从而降低併发症的风险。

临床评估表明，使用其产品治疗的慢性伤口中有 95% 在 90 天内实现完全闭合。所有产品均采用 Regenerex 独特的 QBx 成分，有助于为伤口癒合创造最佳环境。现代伤口敷料（如水胶体和胶原蛋白产品）旨在吸收伤口渗出物，但它们不仅仅是覆盖和保护伤口区域。

Hydrocolloids are colloidal systems where hydrophilic polymers are dispersed in water. These polymers can originate from various sources, including vegetable, animal, microbial, or synthetic origins, and they typically contain numerous hydroxyl groups, which enhance their ability to bind water. The presence of water in varying amounts allows hydrocolloids to exist in different states, such as gels or solutions, depending on the concentration and conditions of the environment.

Hydrocolloid dressings are widely used in clinical settings for various types of wounds due to their ability to create a moist healing environment, absorb exudate, and protect the wound from external contaminants. These dressings contain hydrophilic polymers that form a gel when they come into contact with wound fluid, providing several benefits.

The gel layer created by the hydrocolloid dressing helps maintain a moist environment around the wound, which is crucial for optimal healing. Moisture promotes cell migration, proliferation, and the formation of new tissue, accelerating the healing process.

Market Dynamics: Drivers

Rising incidence of wounds & surgical procedures

The demand for the global hydrocolloids market is driven by multiple factors. One of the primary factors is the rising incidence of wounds & surgical procedures. The increasing number of acute and chronic wounds, particularly among aging populations, is a significant driver of the hydrocolloid market.

Surgical wounds can vary in complexity, from minor incisions to extensive procedures that leave larger, more complex wounds. Hydrocolloid dressings are particularly effective for managing these wounds due to their ability to maintain a moist environment, which is crucial for healing. The number of surgical procedures is the vast population of patients requiring wound care. Each surgery entails a risk of complications, including infections and delayed healing, making effective wound management essential.

Moreover, key players in the industry have technological advancements and product launches that would drive this market growth. Innovations in hydrocolloid dressings include the integration of antimicrobial agents. These agents help prevent infections, a common complication in wound care. By reducing the microbial load at the wound site, antimicrobial hydrocolloid dressings can enhance healing rates and decrease the incidence of wound-related infections.

Also, in August 2023, Scapa Healthcare successfully assisted a global consumer company in launching a hydrocolloid-based medical device in record time. The company aimed to introduce a new medical-grade, skin-friendly hydrocolloid product but lacked the regulatory expertise and capabilities to develop it internally.

Restraints

Factors such as allergic reactions & skin irritations associated with the patches, high cost compared to traditional dressings, and lack of clinical knowledge and training are expected to hamper the market.

Market Segment Analysis

The global hydrocolloids market is segmented based on type, application, end-user, and region.

The burns segment accounted for approximately 54.2% of the global hydrocolloids market share

The burns segment is expected to hold the largest market share over the forecast period. Hydrocolloid dressings are particularly effective in managing burn wounds due to their ability to create and maintain a moist healing environment.

The moisture provided by hydrocolloid dressings plays a crucial role in creating an optimal microenvironment for cell migration, which is essential for wound healing. In a moist environment, cells such as fibroblasts and keratinocytes can more easily move across the wound bed, promoting the formation of granulation tissue and re-epithelialization, ultimately accelerating the overall healing process.

Moreover, key players in the industry product launch that would propel this market growth. For instance, one of the major players Cardinal Health Hydrocolloid Dressing is an advanced wound care product specifically designed to maintain a moist healing environment, which is crucial for effective wound management. This dressing is particularly suitable for various types of wounds, including pressure ulcers, minor burns, and post-operative wounds.

Similarly, 3M introduced the 3M Tegaderm hydrocolloid dressing, Nexcare hydrocolloid, and 3M Nu-Derm standard hydrocolloid dressings are helped to drive this market growth.

Also, other players in the industry introduced the BAND-AID Brand HYDRO SEAL Purpose Hydrocolloid Gel Bandages offer a comprehensive solution for treating minor wounds, providing six key benefits in a single bandage.

Market Geographical Share

North America accounted for approximately 43.1% of the global hydrocolloids market share

North America region is expected to hold the largest market share over the forecast period. The rising prevalence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, significantly drives the hydrocolloids market, particularly in wound care. Chronic wounds present unique challenges in healing and require specialized dressings that can effectively manage moisture levels and promote healing. Hydrocolloid dressings are particularly effective for these purposes, leading to increased demand in the healthcare sector.

Moreover, North America has a growing aging population, which is more susceptible to chronic conditions and wounds. Technological advancements, rising healthcare expenditure, and favorable reimbursement policies are helping to drive this market growth.

For instance, 3M, a leading manufacturer of medical products, announced the launch of a new line of advanced hydrocolloid dressings designed specifically for managing chronic wounds. This innovative product line is expected to have a significant impact on the hydrocolloids market in North America, reflecting 3M's commitment to driving progress in wound care technology.

In addition, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, and key player manufacturers in the hydrocolloids driving this market growth. For instance, in Las Vegas Regenerex in September 2023, Pharma, Inc. announced the formation of its comprehensive management team and plans to start manufacturing operations in the fourth quarter of 2023. The company specializes in wound care products that utilize proprietary formulas aimed at healing wounds quickly, thereby reducing the risk of complications.

Clinical evaluations have demonstrated that 95% of chronic wounds treated with their products achieved complete closure within 90 days. All products incorporate Regenerex's unique QBx ingredients, which help create an optimal environment for wound healing. Modern wound dressings like hydrocolloids and collagen-based products are designed to absorb wound exudate, but they go beyond just covering and protecting the wound area.

Market Segmentation

By Type

Sterile

Non-Sterile

By Application

Burns

Chronic Wounds

Surgical Wounds

Necrotic Wounds

Others

By End-User

Hospitals

Specialty Clinics

Ambulatory Surgical Centres

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the hydrocolloids market include 3M, Amparo medical Technologies., Scapa, Sarasota Medical Products, Cardinal Health., Convatec, Fralock LLC, Hi Tech Products., AMERX Health Care, and DermaRite Industries, LLC. Among others.

Key Developments

In June 2024, The INKEY List launched its Hydrocolloid Invisible Pimple Patches, marking its entry into the pimple patch market. These patches are designed to help reduce the appearance of breakouts, particularly whiteheads, by utilizing hydrocolloid technology combined with active ingredients like salicylic acid. According to Dr. Joshua Zeichner, hydrocolloids are effective because they protect the outer skin layer, absorb excess fluid, and promote healing.

In April 2021, Scapa Healthcare announced enhancements at its Hydrocolloid Technology Center in Orangeburg, New York, as part of its commitment to meeting the increasing global demand for premium medical-grade hydrocolloid adhesive technologies. This facility specializes in the design, development, and manufacturing of hydrocolloid formulations used in various applications, including advanced wound care, ostomy care, and consumer wellness products.

Why Purchase the Report?

To visualize the global hydrocolloids market segmentation based on type, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points on the hydrocolloids market in all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global hydrocolloids market report would provide approximately 62 tables, 54 figures, and 183 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Incidence of Wounds & Surgical Procedures
- 4.1.2. Restraints
  - 4.1.2.1. Allergic Reactions & Skin Irritations Associated with the Patches
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Sterile *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Non-Sterile

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Burns*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Chronic Wounds
7.4. Surgical Wounds
7.5. Necrotic Wounds
7.6. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory Surgical Centres
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. 3M *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Amparo medical Technologies.
11.3. Scapa
11.4. Sarasota Medical Products
11.5. Cardinal Health.
11.6. Convatec
11.7. Fralock LLC
11.8. Hi-Tech Products.
11.9. AMERX Health Care
11.10. DermaRite Industries, LLC. (*LIST NOT EXHAUSTIVE)